Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 4.67B |
| Enterprise Value | 3.31B |
| P/E Ratio | 8.67 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 2.69 |
| Price/Book Ratio | 0.8 |
| Enterprise/Revenue | 1.62 |
| Enterprise/EBITDA | 4.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.3 |
| Operating Margin | 0.34 |
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
| Revenue | 1.39B |
| Revenue/Share | 5.22 |
| Gross Profit | 1.39B |
| EBITDA | 533.4M |
| Net Income | 418.37M |
| Diluted EPS | 1.62 |
| Total Cash | 2.48B |
| Total Cash/Share | 9.57 |
| Total Debt | 41.73M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.52 |
| Book Value Per Share | 17.88 |
| 52-Week Change | -13.15 |
| 52-Week High | 23.98 |
| 52-Week Low | 13.58 |
| Moving Average 50 Days | 16.26 |
| Moving Average 200 Days | 17.9 |
| Average Volume | 4.66M |
| Shares Outstanding | 257.59M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.85 |
| Trailing Annual Dividend Yield | 6.02 |
| Payout Ratio | 0.63 |
| Last Split Factor | 6:5 |
| Last Split Date | April 28, 2026 |